FWM
TMO icon

Focused Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Focused Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-600
Closed -$1.06K – 1122
2023
Q1 		$1.06K Buy
+600
New +$338K ﹤0.01% 862

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Focused Wealth Management's TMO Position: Q2 2026 in Review

Focused Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, buying an estimated $2.4K and bringing the position to 428 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #226.

Focused Wealth Management first reported a position in TMO in Q1 2016 and has held it in 23 quarters since. The position peaked at $279K in Q4 2021. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Focused Wealth Management held 428 shares of Thermo Fisher Scientific worth $215K as of Q2 2026.
  • Focused Wealth Management bought 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.02% of Focused Wealth Management's portfolio in Q2 2026, its #226 holding.
  • Focused Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 23 quarters since.
  • Focused Wealth Management's Thermo Fisher Scientific position peaked at $279K in Q4 2021.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.